Michael Kenison
Corporate Officer/Principal at PROTO LABS, INC.
Net worth: 357 340 $ as of 29/04/2024
Profile
Michael R.
Kenison is currently the Vice President & General Manager-Americas at Proto Labs, Inc. He previously worked as the Vice President-Manufacturing at Cardiac Science, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PROTO LABS, INC.
0.04% | 27/03/2024 | 11,373 ( 0.04% ) | 357 340 $ | 29/04/2024 |
Michael Kenison active positions
| Companies | Position | Start |
|---|---|---|
| PROTO LABS, INC. | Corporate Officer/Principal | 31/05/2021 |
Former positions of Michael Kenison
| Companies | Position | End |
|---|---|---|
Cardiac Science, Inc.
 Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROTO LABS, INC. | Process Industries |
| Private companies | 1 |
|---|---|
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Commercial Services |
- Stock Market
- Insiders
- Michael Kenison
